{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:31:46Z","timestamp":1773300706652,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Dipartimento di Universit\u00e0 di Siena"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00726-016-2207-2","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T09:56:22Z","timestamp":1457690182000},"page":"1477-1489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Homocysteinemia control by cysteine in cerebral vascular patients after methionine loading test: evidences in physiological and pathological conditions in cerebro-vascular and multiple sclerosis patients"],"prefix":"10.1007","volume":"48","author":[{"given":"Monica","family":"Ulivelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"Priora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danila","family":"Di Giuseppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Summa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Margaritis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Frosali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Bartalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Cerase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Di Simplicio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,11]]},"reference":[{"key":"2207_CR1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0021-9150(99)00418-9","volume":"151","author":"A Andersson","year":"2000","unstructured":"Andersson A, Hultberg B, Lindgren A (2000) Redox status of plasma homocysteine and other plasma thiols in stroke patients. Atherosclerosis 151:535\u2013539","journal-title":"Atherosclerosis"},{"key":"2207_CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3988\/jcn.2014.10.4.281","volume":"10","author":"R Ansari","year":"2014","unstructured":"Ansari R, Mahta A, Mallack E, Luo JJ (2014) Hyperhomocysteinemia and neurologic disorders: a review. J Clin Neurol 10:281\u2013288","journal-title":"J Clin Neurol"},{"key":"2207_CR3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/1028415031000115945","volume":"6","author":"HT Besler","year":"2003","unstructured":"Besler HT, Como\u011flu S (2003) Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine levels in patients with multiple sclerosis. Nutr Neurosci 6:189\u2013196","journal-title":"Nutr Neurosci"},{"key":"2207_CR4","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0959-8049(02)00036-9","volume":"38","author":"E Boven","year":"2002","unstructured":"Boven E, Verschraagen M, Hulscher TM, Erkelens CA, Hausheer FH, Pinedo HM, van der Vijgh WJ (2002) BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts. Eur J Cancer 38:1148\u20131156","journal-title":"Eur J Cancer"},{"key":"2207_CR5","doi-asserted-by":"crossref","first-page":"9906","DOI":"10.1021\/bi027434m","volume":"42","author":"S Carballal","year":"2003","unstructured":"Carballal S, Radi R, Kirk MC, Barnes S, Freeman BA, Alvarez B (2003) Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 42:9906\u20139914","journal-title":"Biochemistry"},{"key":"2207_CR6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1432-1033.1994.00363.x","volume":"225","author":"J Christodoulou","year":"1994","unstructured":"Christodoulou J, Sadler PJ, Tucker A (1994) A new structural transition of serum albumin dependent on the state of Cys34. Detection by 1H-NMR spectroscopy. Eur J Biochem 225:363\u2013368","journal-title":"Eur J Biochem"},{"key":"2207_CR7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000207197","volume":"27","author":"MJ Cutler","year":"2009","unstructured":"Cutler MJ, Urquhart BL, Freeman DJ, Spence JD, House AA (2009) Mesna for the treatment of hyperhomocysteinemia in hemodialysis patients. Blood Purif 27:306\u2013310","journal-title":"Blood Purif"},{"key":"2207_CR8","doi-asserted-by":"crossref","first-page":"303654","DOI":"10.1100\/2012\/303654","volume":"2012","author":"B Chiara De","year":"2012","unstructured":"De Chiara B, Sedda V, Parolini M, Campolo J, De Maria R, Caruso R, Pizzi G, Disoteo O, CinziaDellanoce C, Corno AR, Cighetti G, Parodi O (2012) Plasma total cysteine and cardiovascular risk burden: action and interaction. ScientificWorldJournal 2012:303654","journal-title":"ScientificWorldJournal"},{"key":"2207_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-2143(03)00057-X","volume":"142","author":"D Giuseppe Di","year":"2003","unstructured":"Di Giuseppe D, Di Simplicio P, Capecchi PL, Lazzerini PE, Laghi Pasini F (2003) Alteration in the redox state of plasma of heart transplanted patients with moderate hyperhomocysteinemia. J Lab Clin Med 142:21\u201328","journal-title":"J Lab Clin Med"},{"key":"2207_CR10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.lab.2004.06.006","volume":"144","author":"D Giuseppe Di","year":"2004","unstructured":"Di Giuseppe D, Frosali S, Priora R, Di Simplicio F, Buonocore G, Cellesi C, Capecchi PL, Pasini FL, Lazzerini PE, Jakubowski H, Di Simplicio P (2004) The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols. J Lab Clin Med 144:235\u2013245","journal-title":"J Lab Clin Med"},{"key":"2207_CR11","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00726-009-0350-8","volume":"38","author":"D Giuseppe Di","year":"2010","unstructured":"Di Giuseppe D, Ulivelli M, Bartalini S, Battistini S, Cerase A, Passero S, Summa D, Frosali S, Priora R, Margaritis A, Di Simplicio P (2010) Regulation of redox forms of plasma thiols by albumin in multiple sclerosis after fasting and methionine loading test. Amino Acids 38:1461\u20131471","journal-title":"Amino Acids"},{"key":"2207_CR12","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00726-013-1636-4","volume":"46","author":"D Giuseppe Di","year":"2014","unstructured":"Di Giuseppe D, Priora R, Coppo L, Ulivelli M, Bartalini S, Summa D, Margaritis A, Frosali S, Di Simplicio P (2014) The control of hyperhomocysteinemia through thiol exchange mechanisms by mesna. Amino Acids 46:429\u2013439","journal-title":"Amino Acids"},{"key":"2207_CR13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.metabol.2004.09.015","volume":"54","author":"S Doshi","year":"2005","unstructured":"Doshi S, McDowell I, Goodfellow J, Stabler S, Boger R, Allen R, Newcombe R, Lewis M, Moat S (2005) Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypo-homocysteinemia. Metabolism 54:351\u2013360","journal-title":"Metabolism"},{"key":"2207_CR14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","volume":"131","author":"JW Eikelboom","year":"1999","unstructured":"Eikelboom JW, Lonn E, Genest JJ, Hankey G, Hysuf S (1999) Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131:363\u2013375","journal-title":"Ann Intern Med"},{"key":"2207_CR15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/ajcn\/70.6.1016","volume":"70","author":"L El-Khairy","year":"1999","unstructured":"El-Khairy L, Ueland PM, Nygard O, Refsum H, Vollset SE (1999) Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordland homocysteine study. Am J Clin Nutr 70:1016\u20131024","journal-title":"Am J Clin Nutr"},{"key":"2207_CR16","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/01.CIR.103.21.2544","volume":"103","author":"L El-Khairy","year":"2001","unstructured":"El-Khairy L, Ueland PM, Refsum H, Graham IM, Vollset SE (2001) Plasma total cysteine as a risk factor for vascular disease: the European concerted action project. Circulation 103:2544\u20132549","journal-title":"Circulation"},{"key":"2207_CR17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70\u201377","journal-title":"Arch Biochem Biophys"},{"key":"2207_CR18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1053\/ajkd.2003.50054","volume":"41","author":"AN Friedman","year":"2003","unstructured":"Friedman AN, Bostom AG, Laliberty P, Selhub J, Shemin D (2003) The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study. Am J Kidney Dis 41:442\u2013446","journal-title":"Am J Kidney Dis"},{"key":"2207_CR19","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","volume":"277","author":"IM Graham","year":"1997","unstructured":"Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, MeleadyR McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, deValk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G et al (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277:1775\u20131781","journal-title":"JAMA"},{"key":"2207_CR20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0003-9861(03)00091-2","volume":"413","author":"YA Gryzunov","year":"2003","unstructured":"Gryzunov YA, Arroyo A, Vigne JL, Zhao Q, Tyurin VA, Hubel CA, Gandley RE, Vladimirov YA, Taylor RN, Kagan VE (2003) Binding of fatty acids facilitates oxidation of cysteine-34 and converts copper-albumin complexes from antioxidants to prooxidants. Arch Biochem Biophys 413:53\u201366","journal-title":"Arch Biochem Biophys"},{"key":"2207_CR21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ajcp\/106.6.709","volume":"105","author":"SC Guba","year":"1996","unstructured":"Guba SC, Fink LM, Fonseca V (1996) Hyperhomocysteinemia. An emerging and important risk factor for thromboembolic and cardiovascular disease. Am J Clin Pathol 105:709\u2013722","journal-title":"Am J Clin Pathol"},{"key":"2207_CR22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(98)11058-9","volume":"354","author":"GJ Hankey","year":"1999","unstructured":"Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354:407\u2013413","journal-title":"Lancet"},{"key":"2207_CR23","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1373\/clinchem.2006.074302","volume":"52","author":"GL Hortin","year":"2006","unstructured":"Hortin GL, Seam N, Hoehn GT (2006) Bound homocysteine, cysteine, and cysteinylglycine distribution between albumin and globulin. Clin Chem 52:2258\u20132264","journal-title":"Clin Chem"},{"key":"2207_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s002800050594","volume":"39","author":"V Kurowski","year":"1997","unstructured":"Kurowski V, Wagner T (1997) Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy. Cancer Chemother Pharmacol 39:431\u2013439","journal-title":"Cancer Chemother Pharmacol"},{"key":"2207_CR25","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1021\/bi00567a028","volume":"19","author":"SD Lewis","year":"1980","unstructured":"Lewis SD, Misra DC, Shafer JA (1980) Determination of interactive thiol utilization in bovine serum albumin, glutathione, and other thiols by potentiometric difference titration. Biochemistry 19:6129\u20136137","journal-title":"Biochemistry"},{"key":"2207_CR26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0003-2697(92)90456-H","volume":"200","author":"MA Mansoor","year":"1992","unstructured":"Mansoor MA, Svardal AM, Ueland PM (1992) Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 200:218\u2013229","journal-title":"Anal Biochem"},{"key":"2207_CR27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.ATV.15.2.232","volume":"15","author":"MA Mansoor","year":"1995","unstructured":"Mansoor MA, Bergmark C, Svardal AM, Lonning PE, Ueland PM (1995) Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol 15:232\u2013240","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2207_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0166-2236(03)00032-8","volume":"26","author":"MP Mattson","year":"2003","unstructured":"Mattson MP, Shea TB (2003) Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137\u2013146","journal-title":"Trends Neurosci"},{"key":"2207_CR29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1432-1033.1980.tb06022.x","volume":"106","author":"AO Pedersen","year":"1980","unstructured":"Pedersen AO, Jacobsen J (1980) Reactivity of the thiol group in human and bovine albumin at pH 3\u20139, as measured by exchange with 2,2\u2032-dithiodipyridine. Eur J Biochem 106:291\u2013295","journal-title":"Eur J Biochem"},{"key":"2207_CR30","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00726-006-0432-9","volume":"32","author":"J Per\u0142a-Kaj\u00e1n","year":"2007","unstructured":"Per\u0142a-Kaj\u00e1n J, Twardowski T, Jakubowski H (2007) Mechanisms of homocysteine toxicity in humans. Amino Acids 32:561\u2013572","journal-title":"Amino Acids"},{"key":"2207_CR31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.taap.2009.11.003","volume":"242","author":"R Priora","year":"2010","unstructured":"Priora R, Coppo L, Margaritis A, Di Giuseppe D, Frosali S, Summa D, Heo J, Di Simplicio P (2010) The control of S-thiolation by cysteine via gamma-glutamyltranspeptidase and thiol exchanges in erythrocytes and plasma of diamide-treated rats. Toxicol Appl Pharmacol 242:333\u2013343","journal-title":"Toxicol Appl Pharmacol"},{"key":"2207_CR32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1055\/s-2005-872403","volume":"5","author":"I Quere","year":"2005","unstructured":"Quere I, Gris JC, Dauzat M (2005) Homocysteine and venous thrombosis. Sem Vasc Med 5:183\u2013189","journal-title":"Sem Vasc Med"},{"key":"2207_CR33","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.20720","volume":"41","author":"GJ Quinlan","year":"2005","unstructured":"Quinlan GJ, Martin GS, Evans TW (2005) Albumin: biochemical properties and therapeutic potential. Hepatology 41:1211\u20131219","journal-title":"Hepatology"},{"key":"2207_CR34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.2005.072199","volume":"77","author":"GSM Ramsaransing","year":"2006","unstructured":"Ramsaransing GSM, Fokkema MR, Teelken A, Arutjunyan AV, Koch M, De Keyser J (2006) Plasma homocysteine levels in multiple sclerosis. J Neurol Neurosurg Psychiatry 77:189\u2013192","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2207_CR35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.0000109492.65802.AD","volume":"109","author":"A Scholze","year":"2004","unstructured":"Scholze A, Rinder C, Beige J, Riezler R, Zidek W, Tepel M (2004) Acetylcysteine reduces plasma homocysteine concentration and improves pulse pressure and endothelial function in patients with end-stages renal failure. Circulation 109:369\u2013374","journal-title":"Circulation"},{"key":"2207_CR36","doi-asserted-by":"crossref","first-page":"46896","DOI":"10.1074\/jbc.M108451200","volume":"276","author":"S Sengupta","year":"2001","unstructured":"Sengupta S, Whebe C, Majors AK, Ketterer ME, Di Bello PM, Jacobsen DW (2001) Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine mixed disulfide, and cystine in circulation. J Biol Chem 276:46896\u201346904","journal-title":"J Biol Chem"},{"key":"2207_CR37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/gfh447","volume":"20","author":"ME Suliman","year":"2005","unstructured":"Suliman ME, Barany P, Kalantar-Zadeh K, Lindholm B, Stenvinkel P (2005) Homocysteinemia in uremia\u2014a puzzling and conflicting story. Nephrol Dial Transplant 20:16\u201321","journal-title":"Nephrol Dial Transplant"},{"key":"2207_CR38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/prot.21532","volume":"69","author":"D Summa","year":"2007","unstructured":"Summa D, Spiga O, Bernini A, Venditti V, Priora R, Frosali S, Margaritis A, Di Giuseppe D, Niccolai N, Di Simplicio P (2007) Protein-thiol substitution or protein dethiolation by thiol\/disulfide exchange reactions: the albumin model. Proteins 69:369\u2013378","journal-title":"Proteins"},{"issue":"8","key":"2207_CR39","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/jps.20680","volume":"95","author":"BL Urquhart","year":"2006","unstructured":"Urquhart BL, House AA, Cutler MJ, Spence JD, Freeman DJ (2006) Thiol exchange: an in vitro assay that predicts the efficacy of novel homocysteine lowering therapies. J Pharm Sci 95(8):1742\u20131750","journal-title":"J Pharm Sci"},{"issue":"1","key":"2207_CR40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1053\/j.ajkd.2006.10.002","volume":"49","author":"BL Urquhart","year":"2007","unstructured":"Urquhart BL, Freeman DJ, Spence JD, House AA (2007) The effect of mesna on plasma total homocysteine concentration in hemodialysis patients. Am J Kidney Dis 49(1):109\u2013117","journal-title":"Am J Kidney Dis"},{"key":"2207_CR41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/phrs.1999.0519","volume":"40","author":"P Ventura","year":"1999","unstructured":"Ventura P, Panini R, Pasini MC, Scarpetta G, Salvioli G (1999) N-Acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion. Pharmacol Res 40:345\u2013350","journal-title":"Pharmacol Res"},{"key":"2207_CR42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1191\/1352458503ms918oa","volume":"9","author":"M Vrethem","year":"2003","unstructured":"Vrethem M, Mattsson E, Hebelka H, Leerbeck K, Osterberg A, Landtblom AM, Balla B, Nilsson H, Hultgren M, Brattstr\u00f6m L, K\u00e5gedal B (2003) Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. Mult Scler 9:239\u2013245","journal-title":"Mult Scler"},{"key":"2207_CR43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0009-8981(02)00174-2","volume":"322","author":"LL Wu","year":"2002","unstructured":"Wu LL, Wu JT (2002) Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin Chim Acta 322:21\u201328","journal-title":"Clin Chim Acta"},{"key":"2207_CR44","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ijc.25375","volume":"128","author":"J Zacho","year":"2011","unstructured":"Zacho J, Yazdanyar S, Stig E, Bojesen SE, Tybj\u00e6rg-Hansen A, B\u00f8rge G, Nordestgaard BG (2011) Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C\u00a0>\u00a0T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls. Int J Cancer 128:644\u2013652","journal-title":"Int J Cancer"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-016-2207-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-016-2207-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-016-2207-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T12:46:46Z","timestamp":1567687606000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-016-2207-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,11]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["2207"],"URL":"https:\/\/doi.org\/10.1007\/s00726-016-2207-2","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,11]]}}}